Gonadotropin stimulation increases the expression of angiotensin-(1--7) and MAS receptor in the rat ovary.
We have previously shown the presence of immunoreactive angiotensin-(1-7) [Ang-(1-7)] in rat ovary homogenate and its stimulatory effect on estradiol and progesterone production in vitro. In the current study, we investigated the presence and cellular distribution of Ang-(1-7) and the Mas receptor, the expression of Mas and angiotensin-converting enzyme 2 (ACE2) messenger RNA (mRNA), and the enzymatic activity in the rat ovary following gonadotropin stimulation in vivo. Immature female Wistar rats (25 days old) were injected subcutaneously (SC) with equine chorionic gonadotropin (eCG, 20 IU in 0.2 mL) or vehicle 48 hours before euthanasia. Tissue distributions of Ang-(1-7), Mas receptor, and ACE2 were evaluated by immunohistochemistry, along with angiotensin II (Ang II) localization, while the mRNA expression levels of Mas receptor and ACE2 were evaluated by real-time polymerase chain reaction (PCR). In addition, we determined the activity of neutral endopeptidase (NEP), prolyl endopeptidase (PEP), and ACE by fluorometric assays. After eCG treatment, we found strong immunoreactivity for Ang-(1-7) and Mas primarily in the theca-interstitial cells, while Ang II appeared in the granulosa but not in the thecal layer. Equine chorionic gonadotropin treatment increased Mas and ACE2 mRNA expression compared with control animals (3.3- and 2.1-fold increase, respectively; P < .05). Angiotensin-converting enzyme and NEP activities were lower, while PEP activity was higher in the eCG-treated rats (P < .05). These data show gonadotropin-induced changes in the ovarian expression of Ang-(1-7), Mas receptor, and ACE2. These findings suggest that the renin-angiotensin system (RAS) branch formed by ACE2/Ang-(1-7)/Mas, fully expressed in the rat ovary and regulated by gonadotropic hormones, could play a role in the ovarian physiology.
Pereira
Virgínia M
VM
Department of Physiology and Biophysics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Reis
Fernando M
FM
Santos
Robson A S
RA
Cassali
Geovanni D
GD
Santos
Sérgio H S
SH
Honorato-Sampaio
Kinulpe
K
dos Reis
Adelina M
AM
D000803:Angiotensin I / Q000378:metabolism*; D000804:Angiotensin II / Q000378:metabolism; D000085962:Angiotensin-Converting Enzyme 2; D000818:Animals; D005260:Female; D006064:Gonadotropins, Equine / Q000008:administration & dosage*; D007150:Immunohistochemistry; D007279:Injections, Subcutaneous; D015260:Neprilysin / Q000378:metabolism; D010053:Ovary / Q000187:drug effects* / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism*; D007703:Peptidyl-Dipeptidase A / Q000235:genetics / Q000378:metabolism; D016133:Polymerase Chain Reaction; D000085822:Prolyl Oligopeptidases; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D043562:Receptors, G-Protein-Coupled / Q000235:genetics / Q000378:metabolism*; D012697:Serine Endopeptidases / Q000378:metabolism; D013050:Spectrometry, Fluorescence; D013480:Superovulation / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation
D006064:Gonadotropins, Equine; D010446:Peptide Fragments; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D043562:Receptors, G-Protein-Coupled; D000804:Angiotensin II; D000803:Angiotensin I; D007703:Peptidyl-Dipeptidase A; C000705329:Ace2 protein, rat; D000085962:Angiotensin-Converting Enzyme 2; D012697:Serine Endopeptidases; D000085822:Prolyl Oligopeptidases; D015260:Neprilysin; C118790:angiotensin I (1-7)
Eur J Endocrinol. 1995 Dec;133(6):747-53
8548062
J Anat. 2002 Sep;201(3):267-74
12363277
Cell Tissue Res. 1990 Aug;261(2):367-73
2205393
FEBS Lett. 1995 Jan 2;357(1):27-32
8001672
Circ Res. 2000 Sep 1;87(5):E1-9
10969042
J Clin Invest. 1994 Jan;93(1):180-7
8282785
Endocrinology. 2003 May;144(5):1942-8
12697701
Endocrinology. 1990 Jun;126(6):2927-35
2161740
Histol Histopathol. 2002;17(3):739-45
12168782
Trends Endocrinol Metab. 1992 Sep;3(7):243-8
18407106
Am J Obstet Gynecol. 1989 Jan;160(1):8-14
2643330
Acta Endocrinol (Copenh). 1992 Sep;127(3):262-6
1357903
Endocrinology. 1999 Mar;140(3):1236-44
10067849
Endocrinology. 1988 Nov;123(5):2331-40
3139395
Peptides. 2008 Nov;29(11):2024-32
18778744
Am J Hypertens. 1989 May;2(5 Pt 1):395-402
2719823
Braz J Med Biol Res. 1997 Oct;30(10):1157-62
9496431
Endocrinology. 1993 Oct;133(4):1609-16
8404601
Am J Physiol Heart Circ Physiol. 2007 Sep;293(3):H1416-24
17496218
Hypertension. 1985 Mar-Apr;7(2):244-52
2984118
Reprod Toxicol. 1993;7(2):131-5
8499664
Biol Reprod. 1996 Nov;55(5):984-91
8902207
Biol Reprod. 1988 Apr;38(3):695-702
2837296
Hypertension. 1992 Feb;19(2 Suppl):II56-61
1310484
Nature. 1988 Sep 29;335(6189):437-40
3419518
J Pediatr. 2004 Jul;145(1):93-8
15238914
Am J Hypertens. 1999 Oct;12(10 Pt 1):1021-9
10560789
Am J Med Sci. 1988 Apr;295(4):406-8
3284358
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63
12829792
Biochem Pharmacol. 1995 Oct 26;50(9):1451-9
7503796
Endocrinology. 1999 Jun;140(6):2526-32
10342838
Am J Physiol Endocrinol Metab. 2006 Aug;291(2):E221-33
16478781
Science. 1988 Jun 17;240(4859):1660-1
3381087
Reprod Sci. 2009 Mar;16(3):247-56
19164480
Endocrinology. 1996 Apr;137(4):1204-11
8625890
Anim Reprod Sci. 2010 Jan;117(1-2):119-26
19372013
Endocr Rev. 1985 Summer;6(3):371-99
3896767
Front Neuroendocrinol. 1997 Jul;18(3):247-91
9237079
J Ultrastruct Res. 1972 May;39(3):239-50
4337398
Exp Physiol. 2008 May;93(5):519-27
18310257
Fertil Steril. 2006 Aug;86(2):433-9
16769060
J Hypertens. 1991 Jul;9(7):631-8
1653799
J Biol Chem. 1951 Nov;193(1):265-75
14907713
Biol Reprod. 2000 Oct;63(4):1214-8
10993847